相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression
Zhenze Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors
Natalie Timme et al.
TRANSLATIONAL ONCOLOGY (2020)
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
Nathiya Muthalagu et al.
CANCER DISCOVERY (2020)
Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer
Anh-Tien Ton et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Oncogenic MYC amplifies mitotic perturbations
Samantha Littler et al.
OPEN BIOLOGY (2019)
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines
Francesco Mararnpon et al.
CANCER LETTERS (2019)
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Vaishali Aggarwal et al.
BIOMOLECULES (2019)
Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
Lavinia A. Carabet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Franz X. Schaub et al.
CELL SYSTEMS (2018)
Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing
Hui-li Wong et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2018)
PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process
Huijun Xie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox
Jun Yang et al.
CANCER RESEARCH (2017)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
John K. Lee et al.
CANCER CELL (2016)
Drug combination therapy increases successful drug repositioning
Wei Sun et al.
DRUG DISCOVERY TODAY (2016)
Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival
Daibiao Xiao et al.
MOLECULAR CELL (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors
Mark W. Richards et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Targeting the adaptive molecular landscape of castration-resistant prostate cancer
Alexander W. Wyatt et al.
EMBO MOLECULAR MEDICINE (2015)
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Paul C. Boutros et al.
NATURE GENETICS (2015)
Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells
Ju-Yoon Yoon et al.
APOPTOSIS (2014)
Aggressive Variants of Castration-Resistant Prostate Cancer
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2014)
Visceral Disease in Castration-resistant Prostate Cancer
Carmel J. Pezaro et al.
EUROPEAN UROLOGY (2014)
Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis-A Systematic Review and Pooled Analysis
Hai Tao Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential
Himisha Beltran
MOLECULAR CANCER RESEARCH (2014)
Drug Repurposing Identifies a Synergistic Combination Therapy with Imatinib Mesylate for Gastrointestinal Stromal Tumor
Ziyan Y. Pessetto et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Pharmacophore identification of c-Myc inhibitor 10074-G5
Jeremy L. Yap et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
Ana M. Aparicio et al.
CLINICAL CANCER RESEARCH (2013)
Fludarabine: A review of the clear benefits and potential harms
Joshua Lukenbill et al.
LEUKEMIA RESEARCH (2013)
G34, Another Connection between MYCN and a Pediatric Tumor
Miller Huang et al.
CANCER DISCOVERY (2013)
Cdc45 Is a Critical Effector of Myc-Dependent DNA Replication Stress
Seetha V. Srinivasan et al.
CELL REPORTS (2013)
Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
Juan Miguel Mosquera et al.
NEOPLASIA (2013)
Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
Himisha Beltran et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi et al.
LANCET ONCOLOGY (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia
Etienne Moussay et al.
MOLECULAR CANCER (2010)
Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc
Dalia I. Hammoudeh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
William P. Harris et al.
NATURE CLINICAL PRACTICE UROLOGY (2009)
Structural Rationale for the Coupled Binding and Unfolding of the c-Myc Oncoprotein by Small Molecules
Ariele Viacava Follis et al.
CHEMISTRY & BIOLOGY (2008)
Brd4 recruits P-TER to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression
Zhiyuan Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Integrative analysis of genomic aberrations associated with prostate cancer progression
Jung H. Kim et al.
CANCER RESEARCH (2007)
Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts
E. Kikuchi et al.
CANCER GENE THERAPY (2007)
Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal
Mazin A. Moufarij et al.
BLOOD (2006)
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma
Louis Chesler et al.
CANCER RESEARCH (2006)
Statistical practice in high-throughput screening data analysis
N Malo et al.
NATURE BIOTECHNOLOGY (2006)
Neural precursor cycling at sonic speed - N-Myc pedals, GSK-3 brakes
PS Knoepfler et al.
CELL CYCLE (2006)
Tumor dormancy and MYC inactivation: Pushing cancer to the brink of normalcy
CM Shachaf et al.
CANCER RESEARCH (2005)
Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene
JS Hong et al.
CANCER RESEARCH (2004)
Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors
AM Kenney et al.
DEVELOPMENT (2004)
Improved statistical methods for hit selection in high-throughput screening
C Brideau et al.
JOURNAL OF BIOMOLECULAR SCREENING (2003)
Low molecular weight inhibitors of Myc-Max interaction and function
XY Yin et al.
ONCOGENE (2003)
N-myc oncogene expression in neuroblastoma is driven by Sp1 and Sp3
MC Tuthill et al.
MOLECULAR GENETICS AND METABOLISM (2003)
E2F proteins regulate MYCN expression in neuroblastomas
V Strieder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sustained loss of a neoplastic phenotype by brief inactivation of MYC
M Jain et al.
SCIENCE (2002)
Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models
D Voeks et al.
GENE THERAPY (2002)
分享论文
